DocPharma, a healthcare supply chain startup specializing in quick commerce, has raised $2 million in a Pre-Series A round to accelerate its expansion and enhance its supply chain infrastructure across India.
- Raised $2 million from Equentis and other investors
- Plans expansion to 50 cities with 100 new licensed dark stores
- Supports pharmacies, hospitals, and wellness brands with rapid fulfillment
What happened
DocPharma successfully raised $2 million (₹19 crore) in a Pre-Series A funding round led by Equentis with participation from existing backers and angel investors. Founded in 2024 by Saquib Ali, Shashank Rai, and Sagar Chauhan, the startup focuses on quick commerce supply chain solutions targeting healthcare businesses in India.
The funds will be used to expand DocPharma’s presence from 12 cities to 50 across the country, and to establish 100 new licensed dark stores. These stores leverage an AI-powered platform and pharmacist-led compliance to ensure swift and reliable delivery of over 40,000 SKUs in medicines and healthcare products.
Why it matters
DocPharma’s model addresses a significant challenge in the healthcare sector by providing backend supply chain infrastructure to various healthcare platforms, including pharmacies, hospitals, and nutraceutical brands. This enables faster order fulfillment without requiring each partner to build their own logistics network.
The startup’s claimed 95% fulfillment rate and over 8 lakh orders processed to date demonstrate growing demand for quick commerce solutions in India’s healthcare market. As consumer expectations shift towards faster delivery, robust supply chains like DocPharma’s become critical to meet urgent healthcare needs.
What to watch next
DocPharma’s scalability ambitions will be tested as it expands rapidly into new cities, requiring the maintenance of compliance standards and supply chain efficiency across a wider geographic footprint. Success could set a benchmark for supply chain innovation in India’s healthcare quick commerce sector.
Investor enthusiasm in this vertical remains high, echoed by similar fundraises like quick medicine delivery startup Plazza’s $15 million Series A round. Observers will be looking for technological advancements, AI-driven inventory management improvements, and deeper penetration into healthcare and wellness verticals.